Avai Bio (AVAI) Equity Average (2018 - 2025)
Avai Bio's Equity Average history spans 7 years, with the latest figure at -$1.4 million for Q1 2024.
- On a quarterly basis, Equity Average fell 144.51% to -$1.4 million in Q1 2024 year-over-year; TTM through Mar 2024 was -$1.4 million, a 144.51% decrease, with the full-year FY2024 number at -$1.0 million, down 102.14% from a year prior.
- Equity Average hit -$1.4 million in Q1 2024 for Avai Bio, down from -$1.2 million in the prior quarter.
- Over the last five years, Equity Average for AVAI hit a ceiling of $43309.0 in Q3 2020 and a floor of -$1.4 million in Q1 2024.
- Historically, Equity Average has averaged -$516880.5 across 5 years, with a median of -$426355.0 in 2022.
- Biggest five-year swings in Equity Average: surged 140.48% in 2020 and later crashed 288.36% in 2021.
- Tracing AVAI's Equity Average over 5 years: stood at -$130448.5 in 2020, then tumbled by 153.56% to -$330768.5 in 2021, then tumbled by 45.01% to -$479653.5 in 2022, then tumbled by 149.37% to -$1.2 million in 2023, then decreased by 19.87% to -$1.4 million in 2024.
- Business Quant data shows Equity Average for AVAI at -$1.4 million in Q1 2024, -$1.2 million in Q4 2023, and -$992541.5 in Q3 2023.